hydroxyurea has been researched along with Pancytopenia in 9 studies
Pancytopenia: Deficiency of all three cell elements of the blood, erythrocytes, leukocytes and platelets.
Excerpt | Relevance | Reference |
---|---|---|
"Here we report two cases of squamous cell carcinoma of the skin, which appeared in the photo-exposed areas in two elderly patients treated for advanced chronic myeloid leukemia with imatinib." | 1.32 | Squamous cutaneous epithelial cell carcinoma in two CML patients with progressive disease under imatinib treatment. ( Audring, H; Baskaynak, G; Dörken, B; Kreuzer, KA; le Coutre, P; Riess, H; Schwarz, M; Zuber, J, 2003) |
"Hydroxyurea can increase fetal hemoglobin (HbF) and improve the clinical course of sickle cell disease (SCD) patients." | 1.29 | A cautionary note regarding hydroxyurea in sickle cell disease. ( Lubin, BH; Vichinsky, EP, 1994) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (44.44) | 18.2507 |
2000's | 3 (33.33) | 29.6817 |
2010's | 2 (22.22) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Martínez-Trillos, A | 1 |
Gaya, A | 1 |
Maffioli, M | 1 |
Arellano-Rodrigo, E | 1 |
Calvo, X | 1 |
Díaz-Beyá, M | 1 |
Cervantes, F | 1 |
Selvan, SR | 1 |
Sheehy, PF | 1 |
Heinemann, FS | 1 |
Anbuganapathi, S | 1 |
Ault, P | 1 |
Cortes, J | 1 |
Koller, C | 1 |
Kaled, ES | 1 |
Kantarjian, H | 1 |
Baskaynak, G | 1 |
Kreuzer, KA | 1 |
Schwarz, M | 1 |
Zuber, J | 1 |
Audring, H | 1 |
Riess, H | 1 |
Dörken, B | 1 |
le Coutre, P | 1 |
Ishitsuka, K | 1 |
Shirahashi, A | 1 |
Iwao, Y | 1 |
Shishime, M | 1 |
Takamatsu, Y | 1 |
Takatsuka, Y | 1 |
Utsunomiya, A | 1 |
Suzumiya, J | 1 |
Hara, S | 1 |
Tamura, K | 1 |
Vichinsky, EP | 1 |
Lubin, BH | 1 |
Leber, B | 1 |
Walker, IR | 1 |
Rodriguez, A | 1 |
McBride, JA | 1 |
Carter, R | 1 |
Brain, MC | 1 |
Friedman, HD | 1 |
Landaw, SA | 1 |
Fiegl, M | 1 |
Chott, A | 1 |
Seewann, HL | 1 |
Lechner, K | 1 |
Gisslinger, H | 1 |
1 review available for hydroxyurea and Pancytopenia
Article | Year |
---|---|
Recent-onset myelodysplastic syndrome mimicking acute leukemia during infection.
Topics: Acute Disease; Aged; Allopurinol; Anemia, Refractory; Anti-Bacterial Agents; Biopsy; Blood Cell Coun | 1996 |
8 other studies available for hydroxyurea and Pancytopenia
Article | Year |
---|---|
Efficacy and tolerability of hydroxyurea in the treatment of the hyperproliferative manifestations of myelofibrosis: results in 40 patients.
Topics: Adult; Aged; Aged, 80 and over; Anemia; Antisickling Agents; Bone and Bones; Female; Humans; Hydroxy | 2010 |
Bone marrow failure due to T-cell large granular lymphocytic leukemia in a patient with essential thrombocythemia.
Topics: Aged, 80 and over; Antineoplastic Agents; Female; Humans; Hydroxyurea; Leukemia, Large Granular Lymp | 2011 |
Response of idiopathic hypereosinophilic syndrome to treatment with imatinib mesylate.
Topics: Alkylating Agents; Antimetabolites; Benzamides; Bone and Bones; Busulfan; Cladribine; Combined Modal | 2002 |
Squamous cutaneous epithelial cell carcinoma in two CML patients with progressive disease under imatinib treatment.
Topics: Age Factors; Aged; Antineoplastic Agents; Benzamides; Carcinoma, Squamous Cell; Cocarcinogenesis; Co | 2003 |
Bone marrow necrosis in a patient with acute promyelocytic leukemia during re-induction therapy with arsenic trioxide.
Topics: Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Bone Marrow; Bone Marr | 2004 |
A cautionary note regarding hydroxyurea in sickle cell disease.
Topics: Adult; Anemia, Sickle Cell; Blood Transfusion; Cerebral Hemorrhage; Cerebrovascular Disorders; Femal | 1994 |
Reinduction of remission of chronic myeloid leukemia by donor leukocyte transfusion following relapse after bone marrow transplantation: recovery complicated by initial pancytopenia and late dermatomyositis.
Topics: Adult; Bone Marrow Transplantation; Chronic Disease; Combined Modality Therapy; Dermatomyositis; Fem | 1993 |
Persisting bone marrow aplasia following interferon-alpha combined with ara-C for chronic myelogenous leukemia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cytarabine; Dose-Response Relati | 1999 |